Rockwell Medical, Inc. (RWMA)
XMUN 
Summary
RWMA Chart
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates
Rockwell Medical (RMTI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.04 per share a year ago.
Rockwell Medical, Inc. (RWMA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Rockwell Medical, Inc. ever had a stock split?
Rockwell Medical, Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mark Strobeck CEO | XMUN Exchange | US7743744093 ISIN |
| US Country | 157 Employees | - Last Dividend | 1 Jul 2026 Last Split | 27 Jan 1998 IPO Date |
Overview
Rockwell Medical, Inc. operates as a comprehensive healthcare company with a specialized focus on developing, manufacturing, commercializing, and distributing a wide range of hemodialysis products used by dialysis providers across the globe. With its origins dating back to 1996 and headquartered in Wixom, Michigan, Rockwell Medical has established a significant presence in the dialysis care sector. Their primary mission revolves around enhancing the health and quality of life for individuals undergoing hemodialysis by offering innovative products designed to manage hemoglobin levels and remove toxins from the bloodstream effectively.
Products and Services
Rockwell Medical's product lineup is tailored to meet the comprehensive needs of dialysis centers, including a range of hemodialysis concentrates and ancillary products:
- Triferic Dialysate and Triferic AVNU:
These flagship products are designed to maintain hemoglobin levels in adults undergoing hemodialysis. Triferic Dialysate and Triferic AVNU represent a unique approach in anemia management by directly delivering iron to the bone marrow, thus maintaining hemoglobin without increasing iron stores, providing a significant advancement in patient care. - Hemodialysis Concentrates:
The company’s portfolio includes CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, a dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate. These concentrates are essential for the hemodialysis process, aiding in removing toxins and balancing electrolytes in the patient's bloodstream. - Ancillary Products:
Beyond concentrates, Rockwell Medical supplies a range of ancillary products vital for dialysis centers, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and various other items. These products ensure the proper functioning and maintenance of dialysis equipment, contributing to safe and effective patient care.
